Position in GELS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,207
New position
Shares Held
30,161
first reported quarter
Ownership
0.282%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 6 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $557,642,664 across 56 Drug Manufacturers - Specialty & Generic names. GELS ranks #51 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
285,926 | $154,923,283 | |
| 2 | ZTS |
Zoetis Inc.
|
2,011,337 | $144,534,676 | |
| 3 | VTRS |
Viatris Inc
|
5,569,311 | $88,440,657 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
1,000,484 | $34,686,779 | |
| 5 | HLN |
Haleon plc
|
3,669,116 | $34,232,851 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,762,683 | $27,626,830 | |
| 7 | TRLV |
Trulieve Cannabis Corp.
|
1,212,526 | $11,919,129 | |
| 8 | LQDA |
Liquidia Corp
|
141,541 | $11,285,063 |
All Filings in GELS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,207 | 30,161 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||